Yahoo
HKSE - Delayed Quote HKD

Tong Ren Tang Technologies Co. Ltd. (1666.HK)

2.890 -0.010 (-0.34%)
As of 9:50:57 AM GMT+8. Market Open.
Chart Range Bar
Loading chart for 1666.HK
  • Previous Close 2.900
  • Open 2.890
  • Bid 2.875 x --
  • Ask 2.890 x --
  • Day's Range 2.850 - 2.905
  • 52 Week Range 2.850 - 4.950
  • Volume 486,000
  • Avg. Volume 1,418,386
  • Market Cap (intraday) 3.701B
  • Beta (5Y Monthly) 0.82
  • PE Ratio (TTM) 10.70
  • EPS (TTM) 0.270
  • Earnings Date (est.) --
  • Forward Dividend & Yield 0.21 (6.93%)
  • Ex-Dividend Date Jun 16, 2026
  • 1y Target Est 5.41

Tong Ren Tang Technologies Co. Ltd., together with its subsidiaries, produces and distributes Chinese medicine products in Mainland China and Hong Kong. It operates through three segments: The Company; Tong Ren Tang Chinese Medicine; and Others. The company develops, cultivates, processes, and purchases Chinese medicinal raw materials; retails and wholesales Chinese medicine products and healthcare products. It also offers ointments, healthcare products, tea drinks, food, foot care products, biological products, western medicine, and cosmetics. In addition, it provides medical research and development; advertisement; and Chinese medical consultations and treatments. Further, the company produces and processes biochemical products; extracts and processes plants; and offers medical services. Tong Ren Tang Technologies Co. Ltd. was founded in 1669 and is based in Beijing, the People's Republic of China.

www.tongrentangkj.com

3,801

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

1666.HK
30.26%
HANG SENG INDEX (^HSI)
8.34%

1-Year Return

1666.HK
34.72%
HANG SENG INDEX (^HSI)
10.19%

3-Year Return

1666.HK
44.96%
HANG SENG INDEX (^HSI)
33.00%

5-Year Return

1666.HK
35.38%
HANG SENG INDEX (^HSI)
6.12%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY09
Revenue 272.33M
Earnings --
Profit Margin 0.00%

Q4

FY08

Q1

FY09

Q2

FY09

Q3

FY09

0
100M
200M
300M
0.0%

Analyst Insights

View More

Analyst Price Targets

5.13
5.41 Average
2.890 Current
5.69 High

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.32%

  • Return on Assets (ttm)

    2.96%

  • Return on Equity (ttm)

    5.21%

  • Revenue (ttm)

    5.77B

  • Net Income Avi to Common (ttm)

    306.75M

  • Diluted EPS (ttm)

    0.270

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5B

  • Total Debt/Equity (mrq)

    19.01%

  • Levered Free Cash Flow (ttm)

    1.07B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: